Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Small, dense low-density lipoprotein: risk or myth?

Ngoc-Anh Le1

  • 1Emory Lipid Research Laboratory, Emory University School of Medicine, Atlanta Veterans Affairs Medical Center, 1670 Clairmont Road, Mail Code 151, Decatur, GA 30033, USA. ale@emory.edu

Current Atherosclerosis Reports
|February 4, 2003
PubMed
Summary

Small, dense low-density lipoprotein (LDL) particles indicate high risk, while large, buoyant LDL indicates a desirable phenotype. Determining LDL particle diameter is clinically significant for cholesterol management strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Brachytherapy use in cervical cancer: a narrative review.

Gynecology and pelvic medicine·2026
Same author

Outpatient hybrid intracavitary-interstitial brachytherapy for cervical cancer with minimal sedation in a freestanding setting.

Gynecologic oncology reports·2025
Same author

Lipids and C-reactive protein predict anhedonia and reward circuit functional connectivity responses to anti-cytokine and dopaminergic therapies in patients with depression.

Comprehensive psychoneuroendocrinology·2025
Same author

Metabolic flexibility differs by body composition in adults.

Clinical nutrition ESPEN·2021
Same author

Apathy in a high prevalence population of moderate to severe traumatic brain injury: An investigation in Vietnam.

Neuropsychology·2021
Same author

Measuring Postprandial Metabolic Flexibility to Assess Metabolic Health and Disease.

The Journal of nutrition·2021

Area of Science:

  • Cardiovascular Medicine
  • Lipid Metabolism
  • Clinical Biochemistry

Background:

  • Low-density lipoprotein (LDL) particle size is a key determinant of cardiovascular risk.
  • Individuals are classified into phenotype A (large, buoyant LDL; desirable) or phenotype B (small, dense LDL; high risk).
  • Small, dense LDL particles are associated with increased atherogenicity.

Purpose of the Study:

  • To review the clinical significance of LDL particle diameter determination.
  • To propose a strategy for incorporating LDL particle size into the National Cholesterol Education Program's Adult Treatment Panel III guidelines.
  • To enhance cardiovascular risk assessment and patient management.

Main Methods:

  • Review of existing literature on LDL particle size and cardiovascular disease.

Related Experiment Videos

  • Analysis of clinical data correlating LDL phenotype with risk factors.
  • Development of a strategic framework for guideline integration.

    • Main Results:

    • LDL particle diameter is a significant independent predictor of coronary heart disease.
    • Phenotype B is associated with a cluster of metabolic abnormalities, including hypertriglyceridemia and low HDL cholesterol.
    • Current guidelines may not fully leverage LDL particle size information for optimal risk stratification.

    Conclusions:

    • LDL particle diameter determination provides valuable clinical information beyond traditional lipid measures.
    • Incorporating LDL particle size assessment into treatment guidelines can improve cardiovascular risk prediction.
    • A strategic approach is needed to integrate LDL particle size into clinical practice for personalized medicine.